New TUBITAK 1003 Project

Project “The standardization of a screening test for dementia, identification of various environmental factors and the investigation of biomarkers.” partnered with TUBITAK-MAM Genetic Engineering and Biotechnology Institute received a 1003 – Primary Subjects R&D Funding Program Grant. Studies at genome, transcriptome and metabolome level for unlocking molecular pathways of lung cancer and developing new biomarkers is primarily the scope of the project.